Molecules belonging to the class of nonsteroidal anti-inflammatory drugs (NSAIDs) that inhibit COX2 enzyme, which is involved in inflammation and pain processes. It was found that this enzyme is also involved in the growth of cancer cells. The FDA has approved a drug called “Celebrex” for FAP, a condition that raises the risk of colorectal cancer (see family polyposis).
Facebook
Twitter
LinkedIn
WhatsApp
COX-2 Inhibitors
To check if our service suits your case
We need to talk
Improve therapeutic outcomes, prolong life and quality of life, are our main business.
We support access to and expand cancer treatments beyond the standard of care, with the most advanced and innovative treatment options in the world, personally matching the individual cancer patient’s medical condition and with the support of top tier oncologists.
Article categories
קטגוריות המאמרים
Popular topics
Tags
ASCO 2025
Biological Drugs
CAR T treatments
centralny układ nerwowy
Chemotherapy
Genetic Engineering Treatments
Genomic Testing
HER3-DXd
Immunotherapy
innowacyjne terapie onkologiczne
Keytruda
leczenie LMD
leczenie nowotworów mózgu
leki biologiczne
Medical Cannabis
nadzieja dla pacjentów
nowe leczenie raka
nowotwór piersi
onkologia zaawansowana
przerzuty do opon mózgowo-rdzeniowych
rak płuca
Stage 4 Cancer
Targeted Drugs
terapia ADC
TUXEDO-3
